HDAC9 and neoplasm: Besides, Hicks et al. shows that HDAC inhibitors, in addition to significantly enhancing the expression of multiple NK ligands and death receptors resulting in enhanced NK cell-mediated lysis, also increases tumor cell PD-L1 expression both in vitro and in carcinoma xenografts (Hicks et al., 2018).